<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">DeBaun, Michael R.</style></author><author><style face="normal" font="default" size="100%">Hebbel, Robert</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Advances and Challenges in Sickle Cell Anemia</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">2-3</style></pages><abstract><style  face="normal" font="default" size="100%">Sickle cell disease can lead to stroke, which affects about 40% of those with the disease by mid-adolescence. The cognitive damage can lessen IQ and diminish quality of life. Research is leading to helpful strategies, and has also revealed details of the arterial accumulation of the affected red blood cells.</style></abstract><number><style face="normal" font="default" size="100%">55</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>